398 related articles for article (PubMed ID: 16051889)
1. Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.
Duan SZ; Ivashchenko CY; Russell MW; Milstone DS; Mortensen RM
Circ Res; 2005 Aug; 97(4):372-9. PubMed ID: 16051889
[TBL] [Abstract][Full Text] [Related]
2. Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice.
Barbieri M; Di Filippo C; Esposito A; Marfella R; Rizzo MR; D'Amico M; Ferraraccio F; Di Ronza C; Duan SZ; Mortensen RM; Rossi F; Paolisso G
PLoS One; 2012; 7(4):e35999. PubMed ID: 22563432
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Pflugers Arch; 2007 Dec; 455(3):443-54. PubMed ID: 17643263
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
[TBL] [Abstract][Full Text] [Related]
5. Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-deficient mice.
Duan SZ; Usher MG; Foley EL; Milstone DS; Brosius FC; Mortensen RM
Diabetologia; 2010 Jul; 53(7):1493-505. PubMed ID: 20401461
[TBL] [Abstract][Full Text] [Related]
6. Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling.
Sena S; Rasmussen IR; Wende AR; McQueen AP; Theobald HA; Wilde N; Pereira RO; Litwin SE; Berger JP; Abel ED
Endocrinology; 2007 Dec; 148(12):6047-53. PubMed ID: 17823261
[TBL] [Abstract][Full Text] [Related]
7. Controlling cardiomyocyte length: the role of renin and PPAR-{gamma}.
Hinrichs S; Heger J; Schreckenberg R; Wenzel S; Euler G; Arens C; Bader M; Rosenkranz S; Caglayan E; Schlüter KD
Cardiovasc Res; 2011 Feb; 89(2):344-52. PubMed ID: 20884641
[TBL] [Abstract][Full Text] [Related]
8. Exposure to rosiglitazone, a PPAR-γ agonist, in late gestation reduces the abundance of factors regulating cardiac metabolism and cardiomyocyte size in the sheep fetus.
Lie S; Hui M; McMillen IC; Muhlhausler BS; Posterino GS; Dunn SL; Wang KC; Botting KJ; Morrison JL
Am J Physiol Regul Integr Comp Physiol; 2014 Mar; 306(6):R429-37. PubMed ID: 24477540
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
10. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
Rose M; Balakumar P; Singh M
Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
[TBL] [Abstract][Full Text] [Related]
12. PPAR-gamma knockout in pancreatic epithelial cells abolishes the inhibitory effect of rosiglitazone on caerulein-induced acute pancreatitis.
Ivashchenko CY; Duan SZ; Usher MG; Mortensen RM
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G319-26. PubMed ID: 17463185
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
Liang F; Wang F; Zhang S; Gardner DG
Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
[TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
Bao Y; Li R; Jiang J; Cai B; Gao J; Le K; Zhang F; Chen S; Liu P
Mol Cell Biochem; 2008 Oct; 317(1-2):189-96. PubMed ID: 18600431
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
[TBL] [Abstract][Full Text] [Related]
16. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
Ye P; Yang W; Wu SM; Sheng L
Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
[TBL] [Abstract][Full Text] [Related]
17. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ
J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745
[TBL] [Abstract][Full Text] [Related]
18. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
[TBL] [Abstract][Full Text] [Related]
19. Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones.
Lu M; Sarruf DA; Talukdar S; Sharma S; Li P; Bandyopadhyay G; Nalbandian S; Fan W; Gayen JR; Mahata SK; Webster NJ; Schwartz MW; Olefsky JM
Nat Med; 2011 May; 17(5):618-22. PubMed ID: 21532596
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone promotes cardiac hypertrophy and alters chromatin remodeling in isolated cardiomyocytes.
Pharaon LF; El-Orabi NF; Kunhi M; Al Yacoub N; Awad SM; Poizat C
Toxicol Lett; 2017 Oct; 280():151-158. PubMed ID: 28822817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
